Crism Therapeutics (LSE:CRTX) Days Payable : 0.00 (As of Jun. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Crism Therapeutics Days Payable?

Crism Therapeutics's average Accounts Payable for the six months ended in Jun. 2024 was £0.26 Mil. Crism Therapeutics's Cost of Goods Sold for the six months ended in Jun. 2024 was £0.00 Mil.

The historical rank and industry rank for Crism Therapeutics's Days Payable or its related term are showing as below:

LSE:CRTX's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 124.08
* Ranked among companies with meaningful Days Payable only.

Crism Therapeutics's Days Payable declined from Jun. 2023 (1,160.59) to Jun. 2024 (0.00). It may suggest that Crism Therapeutics accelerated paying its suppliers.

Crism Therapeutics Days Payable Historical Data

The historical data trend for Crism Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crism Therapeutics Days Payable Chart

Crism Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

Crism Therapeutics Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Days Payable	Get a 7-Day Free Trial															-	-	1,160.59	-	-

Competitive Comparison of Crism Therapeutics's Days Payable

For the Biotechnology subindustry, Crism Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Crism Therapeutics's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Crism Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Crism Therapeutics's Days Payable falls into.

Save Embed

;

Save Embed

;

Crism Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Crism Therapeutics's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.108	+	0.37)	/	2 )	/	0	*	365
=	0.239					/	0	*	365
=	N/A

Crism Therapeutics's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

	Days Payable (Q: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
=	( (0.37	+	0.151)	/	2 )	/	0	*	365 / 2
=	0.2605					/	0	*	365 / 2
=	N/A

Crism Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of Crism Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Crism Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Crism Therapeutics Corp (LSE:CRTX) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kingston Chambers, P.O. Box 173, Tortola, Road Town, VGB

Website

https://www.crismtherapeutics.com

Crism Therapeutics Corp has developed a drug delivery technology to improve the clinical performance of cancer treatments for solid tumours through the local delivery of chemotherapy drugs. Its product ChemoSeed which is in its clinical trial phase, can be implanted directly into the tumour or the resection margin following the removal of a tumour. The company also provides consultancy and formulation services to its clients assisting them with pharmaceutical formulation and development.

Crism Therapeutics Headlines

No Headlines